ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer

Cui, Hanwei; Yi, Qian; Tian, Min; Yang, Hai Ting; Liang, Yuteng; Huang, Jie; Zeng, Qi; Sun, Weichao; Han, Jian; Guo, Jianxin; Yu, Zhiying; Liu, Wenlan; Ye, Xiufeng

doi:10.7150/jca.72108



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(8):2397-2412. doi:10.7150/jca.72108 This issue Cite

Research Paper

ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer

Hanwei Cui^1,2,3#, Qian Yi^3,5#, Min Tian^4#, Hai Ting Yang^6#, Yuteng Liang³, Jie Huang⁴, Qi Zeng⁴, Weichao Sun³, Jian Han⁴, Jianxin Guo⁴, Zhiying Yu², Wenlan Liu^3✉, Xiufeng Ye^2✉

1. Central Laboratory, Shenzhen Samii Medical Center, Shenzhen, Guangdong 518118, P.R. China.
2. The Department of Gynecology, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, P.R. China.
3. The Central Laboratory, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, P.R. China.
4. The Department of Gynecology & Obstetrics, Daping Hospital, Army Medical University, Chongqing 400042, P.R. China.
5. Department of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
6. Department of Reproductive Medicine, The First Affiliated hospital of Jinan University, Guang zhou, Guangdong, China, 510000.
#These authors contributed equally to this study.

Citation:

Cui H, Yi Q, Tian M, Yang HT, Liang Y, Huang J, Zeng Q, Sun W, Han J, Guo J, Yu Z, Liu W, Ye X. ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. J Cancer 2022; 13(8):2397-2412. doi:10.7150/jca.72108. https://www.jcancer.org/v13p2397.htm

Other styles

Abstract

Adenosine (A)-to-inosine (I) RNA editing is the most prevalent RNA editing mechanism, in which adenosine deaminase acting on RNA 1 (ADAR1) is a major adenosine deaminase. Increasing evidence suggests that editing dysregulation of ADAR1 plays an important role in human tumorigenesis, while the underlying mechanism remains elusive. Here, we demonstrated that ADAR1 was highly expressed in ovarian cancer tissues and negatively correlated with progression free survival of ovarian cancer patients. Importantly, silence of ADAR1 repressed ovarian cancer cell growth and colony formation in vitro and inhibited ovarian cancer cell tumorigenesis in vivo. Further cell cycle and transcriptome profile analysis revealed that silence of ADAR1 in ovarian cancer cells induced cell cycle arrest at G1/G0 stage. Mechanistically, loss of ADAR1 caused R-loop abnormal accumulation, thereby contributing to single stand DNA break and ATR pathway activation. Additionally, ADAR1 interacted with DHX9 to regulate R-loop complex formation, and A-to-I editing of nascent RNA repressed R-loop formation during co-transcriptional process. Together, our results identify a novel ADAR1/R-loop/ATR axis critical for ovarian cancer progression and a potential target for ovarian cancer therapy.

Keywords: Ovarian Cancer, ADAR1, DNA Damage, R-Loop

Citation styles

APA

Cui, H., Yi, Q., Tian, M., Yang, H.T., Liang, Y., Huang, J., Zeng, Q., Sun, W., Han, J., Guo, J., Yu, Z., Liu, W., Ye, X. (2022). ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. Journal of Cancer, 13(8), 2397-2412. https://doi.org/10.7150/jca.72108.

ACS

Cui, H.; Yi, Q.; Tian, M.; Yang, H.T.; Liang, Y.; Huang, J.; Zeng, Q.; Sun, W.; Han, J.; Guo, J.; Yu, Z.; Liu, W.; Ye, X. ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. J. Cancer 2022, 13 (8), 2397-2412. DOI: 10.7150/jca.72108.

NLM

CSE

Cui H, Yi Q, Tian M, Yang HT, Liang Y, Huang J, Zeng Q, Sun W, Han J, Guo J, Yu Z, Liu W, Ye X. 2022. ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. J Cancer. 13(8):2397-2412.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.